The Patent Finder

An Isolated Activin-Binding Actriia Polypeptide Comprising the Seq Id No: 7 and Uses for Promoting Bone Growth

Acceleron Pharma Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 12 of these applications claim priority to application 60/739,462, filed Nov 23, 2005. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 7,951,771Activin-Actriia Antagonists and Uses for Promoting Bone Growth
In force
 · Medium confidence
UsedRemaining
Acceleron Pharma Inc.In forceMedium confidence
US 8,067,360A Method for Promoting Bone Growth Using Activin-Actriia Antagonists
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 8,128,933A Method of Promoting Bone Growth by an Anti-Activin B Antibody
In force
 · High confidence
Acceleron Pharma, Inc.In forceHigh confidence
US 8,486,403A Method of Promoting Bone Growth by an Anti-Activin a Antibody
In force
 · High confidence
Acceleron Pharma, Inc.In forceHigh confidence
US 8,629,109Method for Promoting Bone Growth Using Activin-Actriia Antagonists
In force
 · Low confidence
Acceleron Pharma Inc.In forceLow confidence
US 9,163,075AN ISOLATED POLYNUCLEOTIDE THAT ENCODES AN ActRIIa-Fc FUSION POLYPEPTIDE
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 9,480,742Method of Promoting Bone Growth by an Anti-Actriia Antibody
In force
 · High confidence
Acceleron Pharma, Inc.In forceHigh confidence
US 9,572,865Activin-Actriia Antagonists and Uses for Treating Multiple Myeloma
In force
 · High confidence
Acceleron Pharma, Inc.In forceHigh confidence
US 10,071,135A Method of Identifying an Agent That Promotes Bone Growth or Increases Bone Density
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 10,239,940Method of Promoting Bone Growth by an Anti-Actriia Antibody
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
10 more records in this group · Pro
10 of 20 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 20, including 12 expiring within the 18 months from Nov 19, 2026.
Upgrade to Pro
13 of these are in force and held by Acceleron Pharma Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited